144 related articles for article (PubMed ID: 34935240)
1. Incidence, prevalence and mortality of idiopathic pulmonary fibrosis in Australia.
Cox IA; Otahal P; de Graaff B; Corte TJ; Moodley Y; Zappala C; Glaspole I; Hopkins P; Macansh S; Walters EH; Palmer AJ
Respirology; 2022 Mar; 27(3):209-216. PubMed ID: 34935240
[TBL] [Abstract][Full Text] [Related]
2. Incidence, prevalence and mortality of idiopathic pulmonary fibrosis in England from 2008 to 2018: a cohort study.
Gupta R; Morgan AD; George PM; Quint JK
Thorax; 2024 Jun; 79(7):624-631. PubMed ID: 38688708
[TBL] [Abstract][Full Text] [Related]
3. The economic burden of idiopathic pulmonary fibrosis in Australia: a cost of illness study.
Cox IA; de Graaff B; Ahmed H; Campbell J; Otahal P; Corte TJ; Moodley Y; Goh N; Hopkins P; Macansh S; Walters EH; Palmer AJ
Eur J Health Econ; 2023 Sep; 24(7):1121-1139. PubMed ID: 36289130
[TBL] [Abstract][Full Text] [Related]
4. Global incidence and prevalence of idiopathic pulmonary fibrosis.
Maher TM; Bendstrup E; Dron L; Langley J; Smith G; Khalid JM; Patel H; Kreuter M
Respir Res; 2021 Jul; 22(1):197. PubMed ID: 34233665
[TBL] [Abstract][Full Text] [Related]
5. Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature.
Nalysnyk L; Cid-Ruzafa J; Rotella P; Esser D
Eur Respir Rev; 2012 Dec; 21(126):355-61. PubMed ID: 23204124
[TBL] [Abstract][Full Text] [Related]
6. Unravelling the health and economic burden of interstitial lung diseases in adults in Australia.
Cox IA; de Graaff B; Zheng Q; Corte TJ; Haydn Walters E; Palmer AJ
Aust J Gen Pract; 2024 May; 53(5):333-336. PubMed ID: 38697068
[TBL] [Abstract][Full Text] [Related]
7. Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry.
Jo HE; Glaspole I; Grainge C; Goh N; Hopkins PM; Moodley Y; Reynolds PN; Chapman S; Walters EH; Zappala C; Allan H; Keir GJ; Hayen A; Cooper WA; Mahar AM; Ellis S; Macansh S; Corte TJ
Eur Respir J; 2017 Feb; 49(2):. PubMed ID: 28232409
[TBL] [Abstract][Full Text] [Related]
8. Incidence, prevalence, and national burden of interstitial lung diseases in India: Estimates from two studies of 3089 subjects.
Dhooria S; Sehgal IS; Agarwal R; Muthu V; Prasad KT; Kathirvel S; Garg M; Bal A; Aggarwal AN; Behera D
PLoS One; 2022; 17(7):e0271665. PubMed ID: 35862355
[TBL] [Abstract][Full Text] [Related]
9. Incidence and prevalence of idiopathic interstitial pneumonia and idiopathic pulmonary fibrosis in Korea.
Lee HE; Myong JP; Kim HR; Rhee CK; Yoon HK; Koo JW
Int J Tuberc Lung Dis; 2016 Jul; 20(7):978-84. PubMed ID: 27287654
[TBL] [Abstract][Full Text] [Related]
10. Left-sided heart failure burden and mortality in idiopathic pulmonary fibrosis: a population-based study.
Koteci A; Morgan AD; Portas L; Whittaker HR; Kallis C; George PM; Quint JK
BMC Pulm Med; 2022 May; 22(1):190. PubMed ID: 35549901
[TBL] [Abstract][Full Text] [Related]
11. Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study.
Fernández Pérez ER; Daniels CE; Schroeder DR; St Sauver J; Hartman TE; Bartholmai BJ; Yi ES; Ryu JH
Chest; 2010 Jan; 137(1):129-37. PubMed ID: 19749005
[TBL] [Abstract][Full Text] [Related]
12. Idiopathic pulmonary fibrosis: an Australian perspective.
Prasad J; Holland AE; Glaspole I; Westall G
Intern Med J; 2016 Jun; 46(6):663-8. PubMed ID: 27257148
[TBL] [Abstract][Full Text] [Related]
13. Idiopathic Pulmonary Fibrosis in United States Automated Claims. Incidence, Prevalence, and Algorithm Validation.
Esposito DB; Lanes S; Donneyong M; Holick CN; Lasky JA; Lederer D; Nathan SD; O'Quinn S; Parker J; Tran TN
Am J Respir Crit Care Med; 2015 Nov; 192(10):1200-7. PubMed ID: 26241562
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of idiopathic pulmonary fibrosis: a population-based study in primary care.
Harari S; Davì M; Biffi A; Caminati A; Ghirardini A; Lovato V; Cricelli C; Lapi F
Intern Emerg Med; 2020 Apr; 15(3):437-445. PubMed ID: 31541394
[TBL] [Abstract][Full Text] [Related]
15. Recent trends in pirfenidone and nintedanib use for idiopathic pulmonary fibrosis in Australia.
Cox IA; de Graaff B; Corte TJ; Glaspole I; Chambers DC; Moodley Y; Teoh A; Walters EH; Palmer AJ
Aust Health Rev; 2021 Dec; 45(6):718-727. PubMed ID: 34706811
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of lung cancer among patients with idiopathic pulmonary fibrosis and interstitial lung disease - analysis of institutional and population data.
Yoon JH; Nouraie M; Chen X; Zou RH; Sellares J; Veraldi KL; Chiarchiaro J; Lindell K; Wilson DO; Kaminski N; Burns T; Trejo Bittar H; Yousem S; Gibson K; Kass DJ
Respir Res; 2018 Oct; 19(1):195. PubMed ID: 30285867
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of Idiopathic Pulmonary Fibrosis in Northern Italy.
Harari S; Madotto F; Caminati A; Conti S; Cesana G
PLoS One; 2016; 11(2):e0147072. PubMed ID: 26841042
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology, healthcare utilization, and related costs among patients with IPF: results from a German claims database analysis.
Kreuter M; Picker N; Schwarzkopf L; Baumann S; Cerani A; Postema R; Maywald U; Dittmar A; Langley J; Patel H
Respir Res; 2022 Mar; 23(1):62. PubMed ID: 35305632
[TBL] [Abstract][Full Text] [Related]
19. Characterizing Health Outcomes in Idiopathic Pulmonary Fibrosis using US Health Claims Data.
Mortimer KM; Bartels DB; Hartmann N; Capapey J; Yang J; Gately R; Enger C
Respiration; 2020; 99(2):108-118. PubMed ID: 31982886
[TBL] [Abstract][Full Text] [Related]
20. Australian Idiopathic Pulmonary Fibrosis Registry: vital lessons from a national prospective collaborative project.
Moodley Y; Goh N; Glaspole I; Macansh S; Walters EH; Chapman S; Hopkins P; Reynolds PN; Zappala C; Cooper W; Mahar A; Ellis S; McCormack S; Darbishire W; Wood-Baker R; Corte TJ;
Respirology; 2014 Oct; 19(7):1088-91. PubMed ID: 25123691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
